Vaxcyte (PCVX) Accumulated Expenses (2019 - 2026)
Vaxcyte (PCVX) recorded Accumulated Expenses of $24.73 million in Q2 2026, down 23.2% from $32.21 million a year earlier and down 18.2% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte reported Accumulated Expenses of $31.07 million, up 6.7% from FY2024.
- Annual Accumulated Expenses has a five-year compound annual growth rate of 52.5% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $29.12 million in FY2024 (-51.3%), $59.82 million in FY2023 (+289.0%), $15.38 million in FY2022 (+75.0%) and $8.79 million in FY2021 (+133.3%).
- Quarterly Accumulated Expenses has ranged from $7.74 million in Q1 2022 to $59.82 million in Q4 2023 over the past five years.
- On a year-over-year basis, Accumulated Expenses rose in four of the last eight quarters, with growth averaging 3.3%.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 319.1% in Q3 2021, against a decline of 51.9% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $30.25 million (Q1 2026), $31.07 million (Q4 2025) and $24.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Vaxcyte | 8.24 Bn | 8.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.73 Mn |
| Mar 31, 2026 | 30.25 Mn |
| Dec 31, 2025 | 31.07 Mn |
| Sep 30, 2025 | 24.59 Mn |
| Jun 30, 2025 | 32.21 Mn |
| Mar 31, 2025 | 26.04 Mn |
| Dec 31, 2024 | 29.12 Mn |
| Sep 30, 2024 | 30.75 Mn |
| Jun 30, 2024 | 22.15 Mn |
| Mar 31, 2024 | 54.17 Mn |
| Dec 31, 2023 | 59.82 Mn |
| Sep 30, 2023 | 15.02 Mn |
| Jun 30, 2023 | 19.18 Mn |
| Mar 31, 2023 | 18.35 Mn |
| Dec 31, 2022 | 15.38 Mn |
| Sep 30, 2022 | 13.68 Mn |
| Jun 30, 2022 | 9.89 Mn |
| Mar 31, 2022 | 7.74 Mn |
| Dec 31, 2021 | 8.79 Mn |
| Sep 30, 2021 | 12.03 Mn |
API Access
Vaxcyte Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();